missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human Apolipoprotein O (aa 133-198) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (85%), Rat (85%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-51853 (PA5-51853. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene is a member of the apolipoprotein family. Members of this protein family are involved in the transport and metabolism of lipids. The encoded protein associates with HDL, LDL and VLDL lipoproteins and is characterized by chondroitin-sulfate glycosylation. This protein may be involved in preventing lipid accumulation in the myocardium in obese and diabetic patients. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 3, 4, 5, 12 and 16.
Specifications
Specifications
| Accession Number | Q9BUR5 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 79135 |
| Name | Human Apolipoprotein O (aa 133-198) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 0610008C08Rik; 1110019O03Rik; Apolipoprotein O; APOO; brain my025; FAM121B; family with sequence similarity 121 B; MGC4825; Mic23; MIC26; MICOS complex subunit Mic23; MICOS complex subunit MIC26; My025; MYO25; Protein FAM121B; RGD1565289; UNQ1866/PRO4302 |
| Common Name | Apolipoprotein O |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction